Background: Nephrotic syndrome (NS) is a common childhood renal disease all over the world. This study was designed to evaluate the magnesium level in patients with nephrotic syndrome and its relation to cholesterol.
Introduction
The mineral magnesium is required by virtually every process in the body and deficiencies are fairly common. Magnesium helps regulate blood sugar levels, promotes normal blood pressure, and is known to be involved in energy metabolism and protein synthesis. There is an increased interest in the role of magnesium in preventing and managing disorders such as hypertension, cardiovascular disease, and diabetes. 1 Nephrotic Syndrome (NS) is a clinical entity characterized by massive loss of urinary protein leading to hypoproteinemia resulting in edema. Hyperlipidemia is usually associated with Nephrotic Syndrome. 2 Although pathophysiological aspects of hyperlipidemia have not been completely identified, hypoalbuminemia, increased lipoprotein synthesis and decreased lipoprotein lipase activity are described by various workers. [3] [4] [5] [6] The persistence and severity of lipid changes in serum correlates well with the duration and frequency of the relapses, even during remission which leads to increased risk of atherosclerosis in later life and the development of progressive renal injury.The intensity of hyperlipidemia is usually related to the severity of proteinuria 7, 8 .Mg can act like a natural statin drug and lower bad cholesterol (LDL) reduce triglycerides and increase good cholesterol (HDL). To make cholesterol, it requires a specific enzymes called HMG-CoA reductase. Mg regulates this enzyme so as to maintain only a proper amount of cholesterol. The HMGCoA reductase enzyme is the exact same enzyme that is targeted and inhibited by statin drugs. The inhibiting process is similar to Mg's function except that Mg is the natural way. 9, 10, 11 Biochemcal ration is a common phenomenon in all kidney diseases including nephrotic syndrome and as most intracellular magnesium is bound to proteins, membrane leakiness in nephrotic syndrome causes hypoalbuminemia as well as hypomagnesemia. Mg deficiency causes hypertrophy of jumtraglomerular apparatus located in the kidney. This releases renin which ultimately increases aldosteron, lowering serum Mg and K. 12, 13 So Magnesium level should be checked as a part of evaluation of the severity of the kidney problems. And as serum magnesium level is related to cholesterol level and albumin, so proper supplementation of magnesium can properly manage the disease as they are altered in nephrotic syndrome.
A particular long list of prescription medications have been shown to reduce the body's supply of magnesium. Several types of diuretics, loop diuretics like frusemide and antibiotics have been shown to compromise magnesium status. Other medications that reduce the body's supply of magnesium include corticosteroids and immuno-suppressant drug cyclosporin 1415 . For these reasons the serum magnesium level in patients with idiopathic nephrotic syndrome is an important issue.
Methods
An observational cross sectional study was conducted in the Department of Pediatrics, Dhaka Shishu Hospital, Dhaka with 54sample cases from January 2015 to June 2015, . The Nephrotic cases were selected according to the criteria proposed by International study of kidney diseases in children (ISKDC), that is children with oedema, proteinuria (more than 3 gm in 24 hrs/1.73 m2), hypoproteinemia (serum albumin less than 2.5 gm/dl), hyperlipidemia 13 (M.Phadke, Oct 1990). Exclusion Criteria: Children with liver disorders, oedema due to Kwashiorkor, oedema due to CCF and Children suffering from kidney diseases other than nephrotic syndrome. The samples were analysed for Protein profile (Serum Total protein, serum albumin, serum globulin, A:G ratio, urinary proteins, Blood urea & serum creatinine), Total cholesterol was measured Nephrotic syndrome with initial levels measured within 24 hours of admission to the hospital. Data were collected by interview of the patients, clinical examination and laboratory investigations using the research instrument.
Magnesium measurement
The MG method was used on the Dimension(R) clinical chemistry system. It is an in vitro diagnostic test intended for the quantitative determination of magnesium in human serum, plasma and urine.
The magnesium method is a modification of the methylthymolblue(MTB) complexometric procedure described by Connerty, Lau and Briggs. The barium salt of ethylenebis (oxyethylenenitrilo) teraacetic acid (Ba-EGTA) is used to reduce interference due to calcium which also reacts with MTB.
Cholesterol measurement
Intended use: The CHOL method used on the Dimension® clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of cholesterol in human serum and plasma.
Data were processed and analysed using software SPSS (Statistical Package for Social Sciences) version 22.The test statistics used to analyzed the data were descriptive statistics and correlation coefficient and student t test. Level of significance was set at 0.05 and p < 0.05 was considered significant.
Results
In the present study mean age was 5.51 (±2.56) years , minimum age was 1 year and maximum age was 10 years, maximum age group was > 5 years of old which was 53.7%. majority of them were male baby 39(72.2%). Male female ratio 2:1. (Table -I All the patients had severely high cholesterol level and about 22% of them had mg level at <1.8 mg/dl, 52% of them had mg level at 1.8-2.4 mg/dl and 26% of them had mg level >2.4 mg/dl. The p value is 0.1 which signifies statistically insignificant correlation between the mg level and cholesterol level. (Table V) . Serum magnesium level is low in most cases of frequent relapse nephrotic syndrome.
The present study also reveals there is inverse correlation between serum magnesium level with serum cholesterol, the correlations were statistically not significant (r = -0.179, p = 0.1). (Fig.-1) and maximum age was 10 years, maximum age group was > 5 years of old which was 53.7%. majority of them were male baby 39(72.2%). male female ratio was 2.6 :1.
Hypercholesterolemia is an important feature of nephrotic syndrome. Present study showed, raised level of total cholesterol in first attack,first relapse, infrequent relapse&frequent relapse during active disease.Arije et al 16 observed a significant fall from the high mean pretreatment level of total cholesterol and LDL cholesterol at 4,8,12 weeks of treatment while the fall in mean TG level only became significant at 8 weeks.
The mean HDL cholesterol did not change significantly throughout the treatment. Whereas in cases of relapses, even at the end of steroid therapy there was no significant reduction in serum lipids and found to be persistently high. Merouaniet al 17 observed hyperlipidemia during the active phase of the disease and disappeared with resolution of proteinuria and was persistently abnormal in frequency. Tsukaharaet al 18 observed that children with frequently relapsing nephrotic syndrome have prolonged periods of hypercholestrelemia, even during clinical remission. We noticed that the degree of lipid increase was not that high as reported by Western workers. Milne reported that the total cholesterol in nephrotic syndrome may be higher than 1000 mg%. 19 In Dyaneshet al 20 study the mean total cholesterol was 422.61mg% and highest value was 676 mg%. Banerjee et al in his study observed that the mean total cholesterol was 341mg% and the highest value was 641mg%. 21
Present study showed significant difference of serum magnesium level in frequent relapse but similar serum magnesium level were found in first attack, first relapse and infrequent relapse nephrotic syndrome. Present study also revealed there is inverse correlation between serum magnesium level with serum cholesterol, the correlations were statistically not significant (r = -0.179, p = 0.1). Kobayashi A study in Japan showed serum magnesium was inversely correlated with total cholesterol level. 22 Kobayashi A study in Japan, serum magnesium level was significantly reduced in the untreated condition of disease. Serum magnesium level was gradually elevated to the normal range as the disease improved . It is fairly well established that aldosterone plays an important part in the regulation of magnesium metabolism and incorrect renal excretion of this ion. 23 
Discussion
The observational cross sectional study was carried out in department of Nephrology Dhaka Shishu (Children) Hospital. There were total 54 children enrolled in the study out of these 39 males and 15 female children in the study group. In our study, we found the relation of serum magnesium with serum cholesterol . The mean age was 5.51 (±2.56) years , minimum age was 1 year
There is however, meagre information available concerning magnesium metabolism in the nephroticsyndrome.Proshad, Flink and Mc-Collister described that in the nephrotic syndrome the total magnesium was some what lower than normal, probably because of hypoprotinaemia and that the percentage of ultrafiltrable magnesium was increased in some patients associated with hypoalbunaemia 24 .
From these data, hypomagnesaemia in the nephrotic syndrome may be partly due to secondary hyperaldosteronism which is thought to develop in nephrotics with generalized oedema and partly due to loss of protein.
Conclusion
Our study concludes that serum magnesium level is low in most cases of frequent relapse nephrotic syndrome. There is inverse correlation between serum magnesium levelwith serum cholesterol, but the correlation is statistically not significant.
Limitation
It was a hospital based study. Sample size of this study was not so large to give much strength of the study.
Recommendation
Furthur study should be done to look for any renal structural abnormality particularly tubular problem in those patients.Furthermulticentred study should also be under taken.
